This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Semaglutide Versus Dulaglutide and Liraglutide in Chinese Patients With T2DM: A Multicenter Real-World Study.
Obesity (Silver Spring, Md.), 34(1), 101-113
Citation
Xie, Zeyu; Gan, Bin; Cao, Weiling; Liu, Jiang; Chen, Jisheng. (2026). Semaglutide Versus Dulaglutide and Liraglutide in Chinese Patients With T2DM: A Multicenter Real-World Study.. Obesity (Silver Spring, Md.), 34(1), 101-113. https://doi.org/10.1002/oby.70065